These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11786983)

  • 21. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections?
    Buti M; Jardi R; Allende H; Cotrina M; Rodriguez F; Viladomiu L; Esteban R; Guardia J
    J Med Virol; 1996 May; 49(1):66-9. PubMed ID: 8732862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of HIV and viral hepatitis by analysis of samples from drug related deaths.
    Christensen PB; Kringsholm B; Banner J; Thomsen JL; Cowan S; Stein GF; Jürgensen GW; Grasaasen K; Georgsen J; Pedersen C
    Eur J Epidemiol; 2006; 21(5):383-7. PubMed ID: 16763882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
    Benhamou Y; Dohin E; Lunel-Fabiani F; Poynard T; Huraux JM; Katlama C; Opolon P; Gentilini M
    Lancet; 1995 Feb; 345(8946):396-7. PubMed ID: 7845151
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis.
    Barth RE; Huijgen Q; Taljaard J; Hoepelman AI
    Int J Infect Dis; 2010 Dec; 14(12):e1024-31. PubMed ID: 20870439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral replication in patients with multiple hepatitis virus infections.
    García-Samaniego J; Soriano V; Bravo R; González-Lahoz J; Muñoz F
    Gastroenterology; 1994 Jul; 107(1):322-3. PubMed ID: 8020685
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
    Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects.
    Zylberberg H; Chaix ML; Rabian C; Rouzioux C; Aulong B; Bréchot C; Viard JP; Pol S
    Clin Infect Dis; 1998 May; 26(5):1104-6. PubMed ID: 9597236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral pathogenesis of hepatocellular carcinoma.
    Blum HE; Moradpour D
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S413-20. PubMed ID: 12472973
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
    Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
    Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.
    Alberti A; Pontisso P; Chemello L; Fattovich G; Benvegnù L; Belussi F; De Mitri MS
    J Hepatol; 1995; 22(1 Suppl):38-41. PubMed ID: 7602074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients.
    Ohkawa K; Hayashi N; Yuki N; Hagiwara H; Kato M; Yamamoto K; Eguchi H; Fusamoto H; Masuzawa M; Kamada T
    J Hepatol; 1994 Oct; 21(4):509-14. PubMed ID: 7529271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of hepatitis B core antibody positivity in HCV-infected and HCV/HIV coinfected individuals.
    Cooper C; Kilby D
    Clin Infect Dis; 2004 May; 38(9):1335-7. PubMed ID: 15127355
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of hepatitis C virus in dual and triple hepatitis virus infection.
    Liaw YF
    Hepatology; 1995 Oct; 22(4 Pt 1):1101-8. PubMed ID: 7557857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stealth and cunning: hepatitis B and hepatitis C viruses.
    Wieland SF; Chisari FV
    J Virol; 2005 Aug; 79(15):9369-80. PubMed ID: 16014900
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular mechanisms of hepatitis B and C viruses related to liver carcinogenesis.
    Brechot C
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1189-96. PubMed ID: 9730373
    [No Abstract]   [Full Text] [Related]  

  • 40. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.
    Lu SN; Su WW; Yang SS; Chang TT; Cheng KS; Wu JC; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Chen CH
    Int J Cancer; 2006 Oct; 119(8):1946-52. PubMed ID: 16708389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.